Sanofi (Germany)

The economic impact of pediatric RSV-related lower respiratory tract infection in Germany: evidence from the PAPI study

BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections (LRTI) in infants and young children. While considerable research has described the clinical burden and direct medical costs of RSV in Germany, the broader economic impact...